Literature DB >> 26696594

The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.

Keigo Sekihara1,2, Tomoyuki Hishida2, Shinnosuke Ikemura1,3, Koichi Saruwatari1,3, Masahiro Morise1,3, Takeshi Kuwata1, Satoshi Fujii1, Motohiro Kojima1, Atsushi Ochiai1, Kazuhito Funai4, Keiju Aokage2, Junji Yoshida2, Masahiro Tsuboi2, Genichiro Ishii5.   

Abstract

PURPOSE: Histological vascular invasion (VI) is major predictor of recurrence after surgery for several cancer types. We previously reported that VI with abundant stromal cell infiltrates was a negative prognostic factor in lung adenocarcinoma. This study examined whether stromal cell infiltrates within VI are associated with prognosis in high-grade neuroendocrine carcinoma (HGNEC) of the lung.
METHODS: We investigated the relationship between the frequency and density of VI and recurrence-free survival (RFS) of 60 resected HGNEC patients without adjuvant chemotherapy. We examined prognostic effects of CD204 (+) macrophages, CD34 (+) microvessels and α-smooth muscle actin (+) myofibroblasts within VI. Correlation between expressions of stem cell-related molecules (ALDH-1, Notch 1, CD44) and epithelial-mesenchymal transition-related molecules (E-cadherin, S100A4) in cancer cells within VI and RFS was also analyzed.
RESULTS: Among 60 cases, 51 cases showed VI. Although the presence of VI was a significant predictor for worse RFS (P = 0.04), the frequency and density of VI were not correlated with RFS. The number of CD204 (+) macrophage, CD34 (+) microvessels and α-smooth muscle actin (+) myofibroblasts within VI did not influence on the RFS. On the contrary, cases with higher Notch 1 expression in cancer cells in the VI displayed significantly shorter RFS than lower expression group (7.6 vs. 29.4 months, P = 0.02).
CONCLUSIONS: The current study revealed the presence of stromal cells within VI was not significant predictor for recurrence in HGNEC. This suggests that in HGNEC, unlike adenocarcinoma, intravascular stromal cells are not major contributors to metastasis.

Entities:  

Keywords:  High-grade neuroendocrine carcinoma; Intravascular microenvironment; Large cell neuroendocrine carcinoma; Notch1; Small cell lung cancer; Stromal cells; Vascular invasion

Mesh:

Substances:

Year:  2015        PMID: 26696594     DOI: 10.1007/s00432-015-2098-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

1.  Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).

Authors:  Ryosuke Tsuchiya; Kenji Suzuki; Yukito Ichinose; Yoh Watanabe; Tsutomu Yasumitsu; Naoki Ishizuka; Harubumi Kato
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

2.  Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.

Authors:  Akiko Takahashi; Genichiro Ishii; Tomonari Kinoshita; Tatsuya Yoshida; Shigeki Umemura; Tomoyuki Hishida; Kiyotaka Yoh; Seiji Niho; Koichi Goto; Hironobu Ohmatsu; Yuichiro Ohe; Kanji Nagai; Atsushi Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-07       Impact factor: 4.553

3.  Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients.

Authors:  Ryo Maeda; Genichiro Ishii; Shinya Neri; Kazuhiko Aoyagi; Hironori Haga; Hiroki Sasaki; Kanji Nagai; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2014-02       Impact factor: 15.609

4.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.

Authors:  L A Liotta; J Kleinerman; G M Saidel
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

6.  Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.

Authors:  Akikazu Kawase; Genichiro Ishii; Kanji Nagai; Takeo Ito; Tatsuya Nagano; Yukinori Murata; Tomoyuki Hishida; Mitsuyo Nishimura; Junji Yoshida; Kazuya Suzuki; Atsushi Ochiai
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

7.  Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.

Authors:  Kakeru Hisakane; Koichi Saruwatari; Satoshi Fujii; Keisuke Kirita; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Hironobu Ohmatsu; Takeshi Kuwata; Atsushi Ochiai; Akihiko Gemma; Masahiro Tsuboi; Koichi Goto; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-31       Impact factor: 4.553

8.  Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.

Authors:  Hassan Wael; Ryoji Yoshida; Shinji Kudoh; Kohki Hasegawa; Kanako Niimori-Kita; Takaaki Ito
Journal:  Lung Cancer       Date:  2014-05-13       Impact factor: 5.705

9.  Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.

Authors:  Shotaro Ono; Genichiro Ishii; Kanji Nagai; Teruhisa Takuwa; Junji Yoshida; Mitsuyo Nishimura; Tomoyuki Hishida; Keiju Aokage; Satoshi Fujii; Norihiko Ikeda; Atsushi Ochiai
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

10.  Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Authors:  Elaine Lai-Han Leung; Ronald R Fiscus; James W Tung; Vicky Pui-Chi Tin; Lik Cheung Cheng; Alan Dart-Loon Sihoe; Louis M Fink; Yupo Ma; Maria Pik Wong
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more
  2 in total

1.  Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis.

Authors:  Jiewei Chen; Pengfei Yang; Yongbo Xiao; Yijun Zhang; Jun Liu; Dan Xie; Muyan Cai; Xinke Zhang
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

Review 2.  Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?

Authors:  Elisa Giannetta; Anna La Salvia; Laura Rizza; Giovanna Muscogiuri; Severo Campione; Carlotta Pozza; Annamaria Anita LIvia Colao; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-22       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.